Literature DB >> 2489004

Swine cysticercosis treated with praziquantel, a short report.

A Flisser1, D Gonzalez, J Rodriguez-Carbajal, M Shkurovich, S Cohen, B Fernandez, E Fernandez, M A Collado, I Madrazo, A Plancarte.   

Abstract

Swines with cysticercosis are a useful model to study human disease. A multidisciplinary approach was undertaken to study in detail the effect of praziquantel treatment on hosts and parasites. Computerised tomographic scans showed changes in the number and size of parasites in treated pigs. These changes were more apparent in muscle than in brain cysticerci. Neurophysiologic data were normal in cysticercotic pigs before and after drug treatment. An increase in antibody response was seen immediately after treatment regarding the amount of antibodies and number of antigens recognised. A lower number of polyploid lymphocytes was seen after treatment in cysticercotic pigs as compared to untreated pigs. At different times after treatment pigs were humanely euthanised. Oxygen consumption rate of cysticerci decreased after treatment and evagination was abolished. The inflammatory reaction that surrounded parasites increased in number and type of cells. This was more apparent around cysticerci obtained from muscle than from the brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2489004

Source DB:  PubMed          Journal:  Acta Leiden        ISSN: 0065-1362


  2 in total

1.  Neurocysticercosis in free roaming pigs--a slaughterhouse survey.

Authors:  Anand Prakash; G Sai Kumar; Manoranjan Rout; K Nagarajan; Ram Kumar
Journal:  Trop Anim Health Prod       Date:  2007-08       Impact factor: 1.559

2.  Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.

Authors:  Carla Cangalaya; Javier A Bustos; Juan Calcina; Ana Vargas-Calla; Javier Mamani; Diego Suarez; Gianfranco Arroyo; Armando E Gonzalez; Juan Chacaltana; Cristina Guerra-Giraldez; Siddhartha Mahanty; Theodore E Nash; Héctor H García
Journal:  PLoS Negl Trop Dis       Date:  2017-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.